2. Academic Validation
  3. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

  • Oncotarget. 2015 Dec 1;6(38):40622-41. doi: 10.18632/oncotarget.5872.
Xiong Lei 1,  Yun-Feng Li 1,  Guo-Dong Chen 1,  Di-Peng Ou 2,  Xiao-Xin Qiu 3,  Chao-Hui Zuo 3,  Lian-Yue Yang 1 2
Affiliations

Affiliations

  • 1 Liver Cancer Laboratory, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • 2 Department of Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • 3 Department of Abdominal Surgical Oncology, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
PMID: 26536663 DOI: 10.18632/oncotarget.5872
Abstract

Despite the substantial data supporting the oncogenic role of Ack1, the predictive value and biologic role of Ack1 in hepatocellular carcinoma (HCC) metastasis remains unknown. In this study, both correlations of Ack1 expression with prognosis of HCC, and the role of Ack1 in metastasis of HCC were investigated in vitro and in vivo. Our results showed that Ack1 was overexpressed in human HCC tissues and cell lines. High Ack1 expression was associated with HCC metastasis and determined as a significant and independent prognostic factor for HCC after liver resection. Ack1 promoted HCC invasion and metastasis in vitro and in vivo. Mechanistically, we confirmed that Ack1 enhanced invasion and metastasis of HCC via EMT by mediating Akt phosphorylation. In conclusion, our study shows Ack1 is a novel prognostic biomarker for HCC and promotes metastasis of HCC via EMT by activating Akt signaling.

Keywords

Ack1; hepatocellular carcinoma; metastasis; prognosis.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-15290
    99.95%, Ack1 Inhibitor